Multifaceted regulation of T cells by CD44

Communicative and Integrative Biology

Volumn 3, Issue 6, 2010, Pages 508-512

  Baaten, Bas J G ^a   Li, Cheng Rui ^a   Bradley, Linda M ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Apoptosis; CD44; Cell adhesion; Cell signaling; Extracellular matrix; T cell

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 78650959870     PISSN: None     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.3.6.13495     Document Type: Article

References (58)

1. Ponta H, Sherman L, Herrlich P. CD44: From adhesion molecules to signaling regulators. Nat Rev Molec Cell Biol 2003; 4:33-45.
2. Katoh S, Miyagi T, Taniguchi H, Matsubara Y, Kadota J, Tominaga A, et al. Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol 1999; 162:5058-61.
3. Skelton TP, Zeng C, Nocks A, Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol 1998; 140:431-46.
4. Baaten BJ, Li CR, Deiro MF, Lin MM, Linton PJ, Bradley LM. CD44 regulates survival and memory development in Th1 cells. Immunity 2010; 32:104-15.
5. Johnson P, Ruffell B. CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets 2009; 8:208-20.
6. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Molec Med 2001; 7:213-21.
7. Zoller M, McElwee KJ, Engel P, Hoffmann R. Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/ HeJ mice with alopecia areata. J Invest Dermatol 2002; 118:983-92.
8. DeGrendele HC, Kosfiszer M, Estess P, Siegelman MH. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 1997; 159:2549-53.
9. Lesley J, Howes N, Perschl A, Hyman R. Hyaluronan binding function of CD44 is transiently activated on T cells druing an in vivo immune response. J Exp Med 1994; 180:383-7.
10. Ariel A, Lider O, Brill A, Cahalon L, Savion N, Varon D, et al. Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators. Immunology 2000; 100:345-51.
11. Levesque MC, Haynes BF. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFNgamma. J Immunol 2001; 166:188-96.
12. Levesque MC, Haynes BF. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNFalpha and is inhibited by IL-4 and IL-13. J Immunol 1997; 159:6184-94.
13. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997; 278:672-5.
14. Marhaba R, Freyschmidt-Paul P, Zoller M. In vivo CD44-CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance. Eur J Immunol 2006; 36:3017-32.
15. Nandi A, Estess P, Siegelman M. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity 2004; 20:455-65.
16. Yago T, Shao B, Miner JJ, Yao L, Klopocki AG, Maeda K, et al. E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling. Blood 2010; 116:485-94.
17. Mrass P, Kinjyo I, Ng LG, Reiner SL, Pure E, Weninger W. CD44 mediates successful interstitial navigation by killer T cells and enables efficient antitumor immunity. Immunity 2008; 29:971-85.
18. Bonder CS, Clark SR, Norman MU, Johnson P, Kubes P. Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere. Blood 2006; 107:4798-806.
19. Ley K, Kansas GS. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol 2004; 4:325-35.
20. del Pozo MA, Sanchez-Mateos P, Nieto M, Sanchez-Madrid F. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J Cell Biol 1995; 131:495-508.
21. Rosenman SJ, Ganji AA, Tedder TF, Gallatin WM. Syncapping of human T lymphocyte adhesion/activation molecules and their redistribution during interaction with endothelial cells. J Leukoc Biol 1993; 53:1-10.
22. Charrin S, Alcover A. Role of ERM (ezrin-radixin-moesin) proteins in T lymphocyte polarization, immune synapse formation and in T cell receptormediated signaling. Front Biosci 2006; 11:1987-97.
23. Sanchez-Madrid F, del Pozo MA. Leukocyte polarization in cell migration and immune interactions. EMBO J 1999; 18:501-11.
24. Savinov AY, Rozanov DV, Golubkov VS, Wong FS, Strongin AY. Inhibition of membrane type-1 matrix metalloproteinase by cancer drugs interferes with the homing of diabetogenic T cells into the pancreas. J Biol Chem 2005; 280:27755-8.
25. Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P, Iwatsubo T, et al. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 2004; 165:893-902.
26. Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95:930-5.
27. Okamoto I, Kawano Y, Sasaki J, Nakao M, Matsumoto M, Suga M, et al. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene 1999; 18:1435-46.
28. Okamoto I, Kawano Y, Murakami D, Sasayama T, Araki N, Miki T, et al. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol 2001; 155:755-62.
29. Lammich S, Okochi M, Takeda M, Kaether C, Capell A, Zimmer AK, et al. Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. J Biol Chem 2002; 277:44754-9.
30. Thorne RF, Legg JW, Isacke CM. The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events. J Cell Sci 2004; 117:373-80.
31. Mummert ME, Mummert D, Edelbaum D, Hui F, Matsue H, Takashima A. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J Immunol 2002; 169:4322-31.
32. Do Y, Nagarkatti PS, Nagarkatti M. Role of CD44 and hyaluronic acid (HA) in activation of alloreactive and antigen-specific T cells by bone marrow-derived dendritic cells. J Immunother 2004; 27:1-12.
33. Hegde VL, Singh NP, Nagarkatti PS, Nagarkatti M. CD44 mobilization in allogeneic dendritic cell-T cell immunological synapse plays a key role in T cell activation. J Leukoc Biol 2008; 84:134-42.
34. Pure E, Assoian RK. Rheostatic signaling by CD44 and hyaluronan. Cell Signal 2009; 21:651-5.
35. Galandrini R, Galluzzo E, Albi N, Grossi CE, Velardi A. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J Immunol 1994; 153:21-31.
36. Sugiyama K, Komada Y, Deguchi T, Zhang XL, Azuma E, Ido M, et al. CD3-mediated T cell activation is inhibited by anti-CD44 monoclonal antibodies directed to the hyaluronan-binding region. Immunol Invest 1999; 28:185-200.
37. Bollyky PL, Falk BA, Long SA, Preisinger A, Braun KR, Wu RP, et al. CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10 and TGFbeta. J Immunol 2009; 183:2232-41.
38. Nakano K, Saito K, Mine S, Matsushita S, Tanaka Y. Engagement of CD44 upregulates Fas Ligand expression on T cells leading to activation-induced cell death. Apoptosis 2007; 12:45-54.
39. Ruffell B, Johnson P. Hyaluronan induces cell death in activated T cells through CD44. J Immunol 2008; 181:7044-54.
40. Lin YH, Yang-Yen HF. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem 2001; 276:46024-30.
41. Wittig BM, Johansson B, Zoller M, Schwarzler C, Gunthert U. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J Exp Med 2000; 178:497-507.
42. Naor D, Nedvetski S. CD44 in rheumatoid arthritis. Arthritis Res Ther 2003; 5:105-15.
43. Larkin J, Renukaradhya GJ, Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR. CD44 differentially activates mouse NK T cells and conventional T cells. J Immunol 2006; 177:268-79.
44. Foger N, Marhaba R, Zoller M. CD44 supports T cell proliferation and apoptosis by apposition of protein kinases. Eur J Immunol 2000; 30:2888-99.
45. Lee JL, Wang MJ, Sudhir PR, Chen JY. CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts. Mol Cell Biol 2008; 28:5710-23.
46. Rozsnyay Z. Signaling complex formation of CD44 with src-related kinases. Immunol Lett 1999; 68:101-8.
47. Taher TE, Smit L, Griffioen AW, Schilder-Tol EJ, Borst J, Pals ST. Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes. J Biol Chem 1996; 271:2863-7.
48. Wong NK, Lai JC, Birkenhead D, Shaw AS, Johnson P. CD45 downregulates Lck-mediated CD44 signaling and modulates actin rearrangement in T cells. J Immunol 2008; 181:7033-43.
49. Varadhachary AS, Edidin M, Hanlon AM, Peter ME, Krammer PH, Salgame P. Phosphatidylinositol 3'-kinase blocks CD95 aggregation and caspase-8 cleavage at the death-inducing signaling complex by modulating lateral diffusion of CD95. J Immunol 2001; 166:6564-9.
50. Jones RG, Elford AR, Parsons MJ, Wu L, Krawczyk CM, Yeh WC, et al. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J Exp Med 2002; 196:335-48.
51. Bourguignon LY, Lokeshwar VB, Chen X, Kerrick WG. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J Immunol 1993; 151:6634-44.
52. Su CC, Lin YP, Cheng YJ, Huang JY, Chuang WJ, Shan YS, et al. Phosphatidylinositol 3-kinase/Akt activation by integrin-tumor matrix interaction suppresses Fas-mediated apoptosis in T cells. J Immunol 2007; 179:4589-97.
53. Ward SG, Marelli-Berg FM. Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. Biochem J 2009; 418:13-27.
54. Delgoffe GM, Powell JD. mTOR: taking cues from the immune microenvironment. Immunology 2009; 127:459-65.
55. Zehntner SP, Bourbonniere L, Moore CS, Morris SJ, Methot D, St. Jean M, et al. X-linked inhibitor of apoptosis regulates T cell effector function. J Immunol 2007; 179:7553-60.
56. Song J, So T, Cheng M, Tang X, Croft M. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 2005; 22:621-31.
57. Lee K, Gudapati P, Dragovic S, Spencer C, Joyce S, Killeen N, et al. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 2010; 32:743-53.
58. Varadhachary AS, Peter ME, Perdow SN, Krammer PH, Salgame P. Selective upregulation of phosphatidylinositol 3'-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis. J Immunol 1999; 163:4772-9.